APA (7th ed.) Citation

F, A., F, L., M, L., C, F., M, E., A, L., . . . C, G. (2024). Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: A multicenter real-life experience. Frontiers in oncology, 14, 1370405. https://doi.org/10.3389/fonc.2024.1370405

Chicago Style (17th ed.) Citation

F, Angotzi, et al. "Efficacy and Safety of Venetoclax Plus Hypomethylating Agents in Relapsed/refractory Acute Myeloid Leukemia: A Multicenter Real-life Experience." Frontiers in Oncology 14 (2024): 1370405. https://doi.org/10.3389/fonc.2024.1370405.

MLA (9th ed.) Citation

F, Angotzi, et al. "Efficacy and Safety of Venetoclax Plus Hypomethylating Agents in Relapsed/refractory Acute Myeloid Leukemia: A Multicenter Real-life Experience." Frontiers in Oncology, vol. 14, 2024, p. 1370405, https://doi.org/10.3389/fonc.2024.1370405.